达芬尼因对C48/80诱导的伪过敏反应的抑制作用
Jingyu Zhang1, Ling Hong2, Ping Zhang1
1Department of Pharmacology, School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
International immunopharmacology
|September 10, 2023
概括
达夫尼丁 (DAP) 通过抑制巨细胞降粒和炎症信号,有效抑制伪过敏反应. 这项研究证明了DAP.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 伪过敏反应涉及非IgE介导的巨细胞脱粒.
- 达夫尼丁 (DAP) 已知具有抗炎性质,但其在伪过敏中的作用尚未研究.
研究的目的:
- 为了研究达夫尼丁 (DAP) 的反伪过敏作用.
- 阐明DAP在伪过敏中作用的潜在机制.
主要方法:
- 在体外:用C48/80治疗RBL-2H3细胞以诱导伪过敏.
- 在体内:局部过敏反应,全身过敏反应和的小鼠模型.
- 评估了巨细胞脱粒化,化学激素释放,信号通路 (PLC-IP3R,MAPK) 和炎症标志物.
主要成果:
- 在体外,DAP抑制了巨细胞脱粒化和化学激素的释放.
- DAP减少了PLC-IP3R和MAPK信号通路的激活.
- 在体内,DAP抑制了局部过敏反应,乙氨基酸聚合,血管扩张和巨细胞降粒.
- DAP减轻了系统性过敏反应症状,并减少了组胺,TNF-α和IL-8的释放.
- 在模型中,DAP显著降低了抓行为.
结论:
- 达夫尼丁 (DAP) 对C48/80诱导的伪过敏反应表现出显著的抑制作用.
- DAP通过抑制瘤细胞脱粒和关键炎症信号通路而起作用.
- 研究结果表明,DAP是伪过敏疾病的潜在治疗剂.
更多相关视频
08:25An Ex vivo Mast Cell Degranulation Assay using Crude Peritoneal Exudate Cells and Natural Antigen Stimulation
Published on: April 27, 2021
2.4K
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
12.7K
相关概念视频
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K
Allergic Reactions
27.7K
Overview
27.7K
Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875
Depolarizing Blockers: Pharmocokinetics
352
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
352
